Within our cohort, one BRCA2/TP53 MINAS developed her first breast cancer aged 31 (case 34; Supplementary Table 4), another breast cancer aged 66 and a leiomyosarcoma aged 71. This evidence concerns the gene BRCA2 and breast cancer.